Search

Your search keyword '"Regensberg C"' showing total 12 results
Start Over Author "Regensberg C"
12 results on '"Regensberg C"'

2. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

Author

Brain, E, primary, Garrino, C, additional, Misset, J-L, additional, Garcia Carbonero, I, additional, Itzhaki, M, additional, Cvitkovic, E, additional, Goldschmidt, E, additional, Burki, F, additional, Regensberg, C, additional, Pappo, E, additional, Hagipantelli, R, additional, and Musset, M, additional

Published
1997
Full Text
View/download PDF

5. [Non resectable colonic cancer. Results from a test of chemotherapy with simultaneous prescription of VM26, methyl-CCNU and 5 fluoro-uracile (author's transl)].

Author

Pouillart P, Palangie T, Jouve M, Langlois A, Garcia-Giralt E, Regensberg C, Blic V, Huguenin P, Morin P, Gautier H, Baron A, and Dat-Xuong

Subjects
Adult, Aged, BCG Vaccine administration & dosage, Colonic Neoplasms mortality, Drug Therapy, Combination, Female, Humans, Immunotherapy, Male, Middle Aged, Colonic Neoplasms drug therapy, Fluorouracil administration & dosage, Lomustine administration & dosage, Nitrosourea Compounds administration & dosage, Podophyllotoxin analogs & derivatives, Teniposide administration & dosage
Abstract

Thirty nine patients with non resectable colonic carcinoma entered into a phase II combination chemotherapy trial. The patients were treated with a sequential cyclic combination of 3 drugs: VM 26 (60 mg/m2), methyl-C.C.N.U. (120 mg/m2) and 5 fluoro-uracile. Seventeen patients out of 39 (43.6%) are considered as good responders. The median survival time of the overall of this group is 12.6 months; it is of 15,6 months for good responders and of 7 months for non responders. The simultaneous application of B.C.G. do not change neither the level of responses nor the median of survival time. The good tolerance of this protocol let us to propose this combination as an adjuvant treatment for patients surgically treated for a Dukes'C colonic cancer.

Published
1978

7. [Experimental basis of extracorporeal portacaval derivation].

Author

Testas P and Regensberg C

Subjects
Animals, Catheterization, Dogs, Esophageal and Gastric Varices surgery, Gastrointestinal Hemorrhage surgery, Hemodynamics, Liver Cirrhosis complications, Extracorporeal Circulation, Hypertension, Portal surgery, Saphenous Vein, Splenic Vein
Published
1968

8. [Pancreas, scintigraphy and electronic subtraction].

Author

Desgrez A, Bismuth H, Testas, Regensberg C, Bok B, and Lemort JP

Subjects
Chronic Disease, Diagnosis, Differential, Female, Humans, Male, Methionine, Methods, Motion Pictures, Pancreatic Cyst diagnosis, Pancreatic Neoplasms diagnosis, Pancreatitis diagnosis, Selenium, Subtraction Technique, Electronics, Medical, Pancreatic Diseases diagnosis, Radionuclide Imaging, Technology, Radiologic
Published
1972

9. [Portorenal shunt. Value of preoperative cavorenal exploration].

Author

Regensberg C, Gillot C, Guez D, Maury D, Testas P, and Frileux C

Subjects
Adult, Aged, Female, Humans, Kidney Function Tests, Male, Methods, Middle Aged, Postoperative Complications, Prognosis, Hypertension, Portal surgery, Portacaval Shunt, Surgical, Portal Vein surgery, Renal Veins surgery
Published
1973

12. [May hepatic artery embolization replace surgical desarterialization in hepatic tumors?].

Author

Regensberg C, Richard JP, Doyon D, and Frileux C

Subjects
Antineoplastic Agents administration & dosage, Antineoplastic Agents therapeutic use, Colonic Neoplasms, Contrast Media, Female, Gelatin Sponge, Absorbable administration & dosage, Gelatin Sponge, Absorbable therapeutic use, Humans, Ligation, Liver Neoplasms surgery, Middle Aged, Neoplasm Metastasis, Thrombin administration & dosage, Thrombin therapeutic use, Hepatic Artery, Liver Circulation drug effects, Liver Neoplasms therapy, Thromboembolism chemically induced
Published
1973

Catalog

Books, media, physical & digital resources
See catalog results